Design and characterization of BSA-mycophenolic acid nanocomplexes : Antiviral activity exploration

Copyright © 2024 Elsevier B.V. All rights reserved..

The interactions between bovine serum albumin (BSA) and mycophenolic acid (MPA) were investigated in silico through molecular docking and in vitro, using fluorescence spectroscopy. Dynamic light scattering and scanning electron microscopy were used to figure out the structure of MPA-Complex (MPA-C). The binding affinity between MPA and BSA was determined, yielding a Kd value of (12.0 ± 0.7) μM, and establishing a distance of 17 Å between the BSA and MPA molecules. The presence of MPA prompted protein aggregation, leading to the formation of MPA-C. The cytotoxicity of MPA-C and its ability to fight Junín virus (JUNV) were tested in A549 and Vero cell lines. It was found that treating infected cells with MPA-C decreased the JUNV yield and was more effective than free MPA in both cell line models for prolonged time treatments. Our results represent the first report of the antiviral activity of this type of BSA-MPA complex against JUNV, as assessed in cell culture model systems. MPA-C shows promise as a candidate for drug formulation against human pathogenic arenaviruses.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:265

Enthalten in:

International journal of biological macromolecules - 265(2024), Pt 2 vom: 02. Apr., Seite 131023

Sprache:

Englisch

Beteiligte Personen:

Castañeda Cataña, Mayra A [VerfasserIn]
Dodes Traian, Martín M [VerfasserIn]
Rivas Marquina, Andrea P [VerfasserIn]
Marquez, Agostina B [VerfasserIn]
Arrúa, Eva C [VerfasserIn]
Carlucci, María J [VerfasserIn]
Damonte, Elsa B [VerfasserIn]
Pérez, Oscar E [VerfasserIn]
Sepúlveda, Claudia S [VerfasserIn]

Links:

Volltext

Themen:

27432CM55Q
Antiviral Agents
Arenavirus
Bovine serum albumin
HU9DX48N0T
Journal Article
Mycophenolic Acid
Mycophenolic acid
Nanocomplexes
Serum Albumin, Bovine

Anmerkungen:

Date Completed 18.04.2024

Date Revised 18.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.ijbiomac.2024.131023

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370034767